Chinese Journal of Antituberculosis ›› 2018, Vol. 40 ›› Issue (9): 999-1002.doi: 10.3969/j.issn.1000-6621.2018.09.018
• Review Articles • Previous Articles Next Articles
Long JIN1,Wei-hua HU2,(),Shui-hua LU3,(
)
Received:
2018-04-18
Online:
2018-09-10
Published:
2018-10-17
Contact:
Wei-hua HU,Shui-hua LU
E-mail:15245161620@163.com;tubercle@shaph.org
Long JIN,Wei-hua HU,Shui-hua LU. Effect of diabetes mellitus on multidrug-resistant pulmonary tuberculosis and the countermeasures[J]. Chinese Journal of Antituberculosis, 2018, 40(9): 999-1002. doi: 10.3969/j.issn.1000-6621.2018.09.018
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2018.09.018
[1] | 唐神结, 许绍发, 李亮 . 耐药结核病学. 北京: 人民卫生出版社, 2014: 62-64. |
[2] | World Health Organization. Global tuberculosis report 2017. Geneva: World Health Organization, 2017. |
[3] |
Xu Y, Wang L, He J , et al. Prevalence and control of diabetes in Chinese adults. JAMA, 2013,310(9):948-959.
doi: 10.1001/jama.2013.168118 URL |
[4] | International Diabetes Federation. IDF Diabetes Atlas. 6th ed. Brussels: International Diabetes Federation, 2013. |
[5] | 李强, 刘玉琴, 李雨泽 . 应高度重视糖尿病并发结核病的防治与转化医学研究. 中国防痨杂志, 2017,39(12):1264-1267. |
[6] |
Rifat M, Milton AH, Hall J , et al. Development of multidrug resistant tuberculosis in Bangladesh: a case-control study on risk factors. PLoS One, 2014,9(8):e105214.
doi: 10.1371/journal.pone.0105214 URL |
[7] | Magee MJ, Kempker RR, Kipiani M , et al. Diabetes mellitus is associated with cavities, smear grade, and multidrug-resis-tant tuberculosis in Georgia. Int J Tuberc Lung Dis, 2015,19(6):685-692. |
[8] |
Chang JT, Dou HY, Yen CL , et al. Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance. J Formos Med Assoc, 2011,110(6):372-381.
doi: 10.1016/S0929-6646(11)60055-7 URL |
[9] |
Mehta S, Yu EA, Ahamed SF , et al. Rifampin resistance and diabetes mellitus in a cross-sectional study of adult patients in rural South India. BMC Infect Dis, 2015,15:451.
doi: 10.1186/s12879-015-1204-5 URL |
[10] | 刁丽丽 . 复治肺结核并糖尿病患者耐药率及与血糖水平的关系. 内科急危重症杂志, 2016,22(1):33-34. |
[11] |
宋其生, 蔡春葵, 任彦薇 , 等. 大连市耐多药结核危险因素分析. 大连医科大学学报, 2015,37(1):45-48.
doi: 10.11724/jdmu.2015.01.11 URL |
[12] |
Mi F, Jiang G, Du J , et al. Is resistance to anti-tuberculosis drugs associated with type 2 diabetes mellitus? A register review in Beijing, China. Glob Health Action, 2014,7:24022.
doi: 10.3402/gha.v7.24022 URL |
[13] |
段慧萍 . 合并糖尿病的肺结核54例耐药情况分析. 基层医学论坛, 2012,16(32):4233-4234.
doi: 10.3969/j.issn.1672-1721.2012.32.014 URL |
[14] | 宋瑞娟, 夏露, 卢水华 . 糖尿病与耐药肺结核的关系. 中国防痨杂志, 2017,39(1):11-15. |
[15] |
Magee MJ, Kempker RR, Kipiani M , et al. Diabetes mellitus, smoking status, and rate of sputum culture conversion in patients with multidrug-resistant tuberculosis: a cohort study from the country of Georgia. PLoS One, 2014,9(4):e94890.
doi: 10.1371/journal.pone.0094890 URL |
[16] |
Kang YA, Kim SY, Jo KW , et al. Impact of diabetes on treatment outcomes and long-term survival in multidrug-resistant tuberculosis. Respiration, 2013,86(6):472-478.
doi: 10.1159/000348374 URL |
[17] |
赵文静, Shi LZ, Fonseca VA , 等. 糖尿病患者结核病患病情况及危险因素分析. 中国公共卫生, 2013,29(10):1413-1416.
doi: 10.11847/zgggws2013-29-10-03 URL |
[18] |
沈洁, 封士成 . 58例耐多药肺结核合并糖尿病患者高分辨率CT的影像特点. 当代临床医刊, 2016,29(4):2325.
doi: 10.3969/j.issn.2095-9559.2016.04.004 URL |
[19] | 康英英, 成志锋 . 肺结核并发糖尿病的治疗与护理. 中国防痨杂志, 2017,39(12):1273-1277. |
[20] | 孙利华 . 17例耐多药肺结核合并糖尿病患者的资料分析. 临床肺科杂志, 2012,17(1):153. |
[21] | 银春莲 . 耐多药肺结核合并糖尿病98例临床观察. 中国医药导刊, 2013,15(9):1508-1509. |
[22] | 盛云峰, 邱美华, 鲍志坚 , 等. 耐多药肺结核合并糖尿病患者肺部感染病原菌与危险因素分析. 中华医院感染学杂志, 2016,26(9):1939-1941. |
[23] |
Dey D, Ray R, Hazra B . Antitubercular and antibacterial activity of quinonoid natural products against multi-drug resis-tant clinical isolates. Phytother Res, 2014,28(7):1014-1021.
doi: 10.1002/ptr.v28.7 URL |
[24] |
Koul A, Arnoult E, Lounis N , et al. The challenge of new drug discovery for tuberculosis. Nature, 2011,469(7331):483-490.
doi: 10.1038/nature09657 URL pmid: 21270886 |
[25] | 杨维娜, 李冬民, 曹三成 , 等. 2型糖尿病各并发症及影响因素的临床分析. 临床和实验医学杂志, 2012,11(8):573-575. |
[26] |
苏伟, 阮云洲, 赵津 , 等. 91例耐多药肺结核患者抗结核药物不良反应发生情况分析. 中国防痨杂志, 2014,36(7):570-575.
doi: 10.3969/j.issn.1000-6621.2014.07.010 URL |
[27] |
中国防痨协会. 耐药结核病化学治疗指南(2015). 中国防痨杂志, 2015,37(5):421-469.
doi: 10.3969/j.issn.1000-6621.2015.05.001 URL |
[28] | 李艳静, 高微微, 常占平 , 等. 肺结核合并糖尿病对抗结核药物血药浓度的影响. 中国防痨杂志, 2012,34(1):23-25. |
[29] |
Bodnar T, Starr K, Halter JB . Linezolid-associated hypoglycemia in a 64-year-old man with type 2 diabetes. Am J Geriatr Pharmacother, 2011,9(1):88-92.
doi: 10.1016/j.amjopharm.2011.02.002 URL pmid: 21459312 |
[30] |
Chung-Delgado K, Guillen-Bravo S, Revilla-Montag A , et al. Mortality among MDR-TB cases: comparison with drug-susceptible tuberculosis and associated factors. PLoS One, 2015,10(3):e0119332.
doi: 10.1371/journal.pone.0119332 URL |
[31] | Salindri AD, Kipiani M, Kempker RR , et al. Diabetes reduces the rate of sputum culture conversion in patients with newly diagnosed multidrug-resistant tuberculosis. Open Forum Infect Dis, 2016, 3(3): ofwl26. |
[32] |
Kumar NP, Sridhar R, Nair D , et al. Type 2 diabetes mellitus is associated with altered CD8+ T and natural killer cell function in pulmonary tuberculosis . Immunology, 2015,144(4):677-686.
doi: 10.1111/imm.12421 URL |
[33] |
Berezin AE, Kremzer AA, Samura TA , et al. Impaired immune phenotype of circulating endothelial-derived microparticles in patients with metabolic syndrome and diabetes mellitus. J Endocrinol Invest, 2015,38(8):865-874.
doi: 10.1007/s40618-015-0273-z URL |
[34] |
Brill KJ, Li Q, Larkin R , et al. Human natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms. Infect Immun, 2001,69(3):1755-1765.
doi: 10.1128/IAI.69.3.1755-1765.2001 URL |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||